Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma

Stephane Depil, Xavier Leleu, Jean Baptiste Micol, Celine Berthon, Jean Luc Laï, Francis Bauters, Bruno Quesnel, Thierry Facon

Résultats de recherche: Contribution à un journalArticleRevue par des pairs

10 Citations (Scopus)

Résumé

In order to evaluate the prognostic factors for progression and survival in patients with a low tumor mass asymptomatic multiple myeloma (MM), we studied 59 patients who had a long term follow-up. Cytogenetic abnormalities (using conventional cytogenetics) were observed in 14 out of 45 analyzable patients (31%). An abnormal karyotype and a bone marrow (BM) plasmacytosis > 15% were found to be adverse prognostic factors for progression in univariate and multivariate analysis.

langue originaleAnglais
Pages (de - à)2481-2484
Nombre de pages4
journalLeukemia and Lymphoma
Volume45
Numéro de publication12
Les DOIs
étatPublié - 1 déc. 2004
Modification externeOui

Contient cette citation